Brought to you by 
Public offering nets $109.3mm for Tandem Diabetes
Aug 2018
Executive Summary
Tandem Diabetes Care Inc. (manufactures and sells insulin pumps and glucose monitoring devices) netted $109.3mm through the public sale of 4mm common shares (including the overallotment) at $28.50. The company will use some or all of the proceeds to repay debt under an existing term loan agreement with Capital Royalty.
Deal Industry
-
In Vitro Diagnostics
- Glucose Testing
-
Medical Devices
- Monitoring Equipment & Devices
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Public offering nets $109.3mm for Tandem Diabetes
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice